ArticleCureus2026
The Clonal Conundrum: Clonal CD4⁺ Cutaneous Lymphoid Infiltrate in a Toddler Along a Reactive Primary Cutaneous CD4⁺ Small/Medium T-cell Lymphoproliferative Disorder (PCSM-TCLPD) Spectrum.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous lymphoid infiltrates in children pose a diagnostic challenge because reactive lymphoid processes and low-grade lymphoproliferative disorders can share overlapping clinical, histopathologic, and molecular features. We report a case of a two-year-old child presenting with a persistent erythematous plaque on the right cheek following a presumed mosquito bite. The lesion was refractory to topical antibiotics and corticosteroids. Histopathologic examination revealed a dense CD4⁺ T-cell-predominant dermal infiltrate, and molecular studies demonstrated both beta and gamma T-cell receptor (TCR) clonality. Although the findings were histopathologically compatible with primary cutaneous CD4⁺ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD), the patient's age, clinical context, and subsequent clinical course suggested an atypical clonal reactive T-cell process. Following a diagnostic biopsy, the lesion demonstrated partial clinical regression. A conservative management strategy with clinical observation and serial photography was adopted, avoiding unnecessary systemic therapy. This case highlights the diagnostic gray zone between clonal reactive lymphoid proliferations and PCSM-TCLPD in very young children, an age group in which such presentations are exceedingly rare, and emphasizes the importance of clinicopathologic correlation, multidisciplinary evaluation, and cautious management. It also raises awareness that these entities may exist along a biological spectrum rather than representing entirely distinct processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.